| Window | Theses | Resolved | Wins | Win rate | Avg return | Median return |
|---|---|---|---|---|---|---|
| 1d | 0 | 0 | 0 | — | — | — |
| 3d | 5 | 5 | 2 | 40% | -0.3% | +0.1% |
| 1w | 5 | 5 | 2 | 40% | -0.2% | +0.9% |
| 1m | 5 | 5 | 2 | 40% | +0.9% | +3.0% |
| 3m | 5 | 5 | 4 | 80% | +14.1% | +11.6% |
| 6m | 5 | 5 | 3 | 60% | +17.2% | +12.8% |
| 1y | 5 | 5 | 3 | 60% | +33.5% | +31.1% |
Past performance does not predict future results. Informational only, not investment advice.
Author is holding UNH calls as part of remaining 15% portfolio allocation. Positioning suggests bullish bias on healthcare amid market uncertainty.
Author is currently holding QQQ puts, representing a bearish stance. Position reflects expectation of near-term pullback or correction amid tariff uncertainty.
Author repeatedly YOLO'd into GOOGL calls on major pullbacks, including after Apple congressional testimony news. Despite weak recent performance, the strategy of buying dips generated substantial profits.
Author consistently profited from scalping NVDA options, using near or at-the-money calls 2-5 months out. Strategy exploits pullbacks for 20-50% gains.
HIMS was a winning trade on calls purchased around $10 and sold around $20-$24. Author regrets not holding longer, implying upside potential was underestimated.
End of results.